Dr. Vasil Peev, M.D

NPI: 1427229087
Total Payments
$22,436
2024 Payments
$2,345
Companies
13
Transactions
53
Medicare Patients
2,948
Medicare Billing
$438,510

Payment Breakdown by Category

Other$13,610 (60.7%)
Consulting$5,154 (23.0%)
Food & Beverage$3,539 (15.8%)
Travel$128.35 (0.6%)
Education$5.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Honoraria $13,610 8 60.7%
Consulting Fee $5,154 5 23.0%
Food and Beverage $3,539 36 15.8%
Travel and Lodging $128.35 3 0.6%
Education $5.00 1 0.0%

Top Paying Companies

Company Total Records Latest Year
Horizon Therapeutics plc $14,270 17 $0 (2022)
Mallinckrodt Enterprises LLC $3,997 12 $0 (2019)
CALLIDITAS THERAPEUTICS US INC. $2,376 6 $0 (2024)
Alexion Pharmaceuticals, Inc. $462.04 4 $0 (2017)
PFIZER INC. $385.78 2 $0 (2018)
Novartis Pharmaceuticals Corporation $215.00 2 $0 (2019)
Veloxis Pharmaceuticals, Inc. $196.98 3 $0 (2019)
One Lambda, Inc. $146.39 1 $0 (2024)
Otsuka Pharmaceutical Development & Commercialization, Inc. $124.37 2 $0 (2018)
ANI Pharmaceuticals, Inc. $120.69 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,345 4 CALLIDITAS THERAPEUTICS US INC. ($2,198)
2023 $325.46 4 Calliditas Therapeutics US Inc. ($155.03)
2022 $1,986 6 Horizon Therapeutics plc ($1,964)
2021 $5,329 5 Horizon Therapeutics plc ($5,329)
2020 $4,840 7 Horizon Therapeutics plc ($4,817)
2019 $2,524 5 Horizon Therapeutics plc ($2,160)
2018 $994.01 9 Mallinckrodt LLC ($483.86)
2017 $4,092 13 Mallinckrodt LLC ($3,389)

All Payment Transactions

53 individual payment records from CMS Open Payments — Page 1 of 3

Date Company Product Nature Form Amount Type
10/21/2024 CALLIDITAS THERAPEUTICS US INC. TARPEYO (Drug) Consulting Fee Cash or cash equivalent $2,000.00 General
Category: Nephrology
10/01/2024 CALLIDITAS THERAPEUTICS US INC. TARPEYO (Drug) Food and Beverage In-kind items and services $142.85 General
Category: Nephrology
03/20/2024 One Lambda, Inc. Food and Beverage Cash or cash equivalent $146.39 General
01/18/2024 CALLIDITAS THERAPEUTICS US INC. TARPEYO (Drug) Food and Beverage In-kind items and services $55.60 General
Category: Nephrology
08/17/2023 Calliditas Therapeutics US Inc. TARPEYO (Drug) Food and Beverage In-kind items and services $106.58 General
Category: Nephrology
07/11/2023 ANI Pharmaceuticals, Inc. PURIFIED CORTROPHIN GEL (Drug) Food and Beverage In-kind items and services $120.69 General
Category: Treatment of certain chronic autoimmune disorders, including acute exacerbations of MS and RA
05/19/2023 Calliditas Therapeutics US Inc. TARPEYO (Drug) Food and Beverage In-kind items and services $48.45 General
Category: Nephrology
05/04/2023 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Food and Beverage In-kind items and services $49.74 General
Category: Rare Disease
08/19/2022 Horizon Therapeutics plc KRYSTEXXA (Biological) Food and Beverage In-kind items and services $108.36 General
Category: KRYSTEXXA
08/10/2022 CALLIDITAS THERAPEUTICS US INC. TARPEYO (Drug) Food and Beverage In-kind items and services $22.39 General
Category: Nephrology
06/06/2022 Horizon Therapeutics plc KRYSTEXXA (Biological) Food and Beverage In-kind items and services $22.62 General
Category: KRYSTEXXA
06/05/2022 Horizon Therapeutics plc KRYSTEXXA (Biological) Honoraria Cash or cash equivalent $1,620.00 General
Category: KRYSTEXXA
06/05/2022 Horizon Therapeutics plc KRYSTEXXA (Biological) Food and Beverage In-kind items and services $138.09 General
Category: KRYSTEXXA
06/05/2022 Horizon Therapeutics plc KRYSTEXXA (Biological) Consulting Fee In-kind items and services $74.80 General
Category: KRYSTEXXA
09/10/2021 Horizon Therapeutics plc PROCYSBI (Drug) Honoraria Cash or cash equivalent $2,250.00 General
Category: PROCYSBI
08/12/2021 Horizon Therapeutics plc KRYSTEXXA (Biological) Food and Beverage In-kind items and services $126.05 General
Category: KRYSTEXXA
06/17/2021 Horizon Therapeutics plc KRYSTEXXA (Biological) Honoraria Cash or cash equivalent $1,620.00 General
Category: KRYSTEXXA
06/17/2021 Horizon Therapeutics plc KRYSTEXXA (Biological) Consulting Fee In-kind items and services $73.00 General
Category: KRYSTEXXA
02/25/2021 Horizon Therapeutics plc PROCYSBI (Drug) Honoraria Cash or cash equivalent $1,260.00 General
Category: PROCYSBI
12/11/2020 Horizon Therapeutics plc PROCYSBI (Drug) Honoraria Cash or cash equivalent $1,080.00 General
Category: PROCYSBI
06/24/2020 Mallinckrodt Hospital Products Inc. ACTHAR (Biological) Food and Beverage In-kind items and services $23.10 General
Category: IMMUNOLOGY
06/16/2020 Horizon Therapeutics plc PROCYSBI (Drug) Honoraria Cash or cash equivalent $1,260.00 General
Category: PROCYSBI
02/21/2020 Horizon Therapeutics plc KRYSTEXXA (Biological) Food and Beverage In-kind items and services $32.99 General
Category: KRYSTEXXA
02/21/2020 Horizon Therapeutics plc KRYSTEXXA (Biological) Food and Beverage In-kind items and services $32.00 General
Category: KRYSTEXXA
02/17/2020 Horizon Therapeutics plc KRYSTEXXA (Biological) Honoraria Cash or cash equivalent $2,360.00 General
Category: KRYSTEXXA

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 9 676 1,184 $315,989 $112,117
2022 10 598 1,196 $311,022 $108,237
2021 12 845 1,404 $331,509 $115,131
2020 14 829 1,414 $350,021 $103,025
Total Patients
2,948
Total Services
5,198
Medicare Billing
$438,510
Procedure Codes
45

All Medicare Procedures & Services

45 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2023 197 345 $110,400 $39,068 35.4%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 174 404 $70,700 $26,739 37.8%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 100 214 $54,142 $21,686 40.1%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 84 95 $31,920 $10,439 32.7%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 59 63 $31,248 $9,192 29.4%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2023 12 12 $5,580 $1,706 30.6%
90935 Hemodialysis procedure with physician evaluation Facility 2023 23 23 $5,405 $1,276 23.6%
99221 Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes Facility 2023 16 17 $4,284 $1,191 27.8%
99443 Telephone medical discussion with physician, 21-30 minutes Facility 2023 11 11 $2,310 $820.50 35.5%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2022 190 339 $108,480 $40,488 37.3%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 131 431 $75,425 $25,575 33.9%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 83 206 $52,118 $17,923 34.4%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 47 54 $26,784 $9,160 34.2%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 59 64 $21,504 $7,437 34.6%
99443 Telephone medical discussion with physician, 21-30 minutes Facility 2022 30 37 $7,770 $2,128 27.4%
99205 New patient office or other outpatient visit, 60-74 minutes Facility 2022 16 16 $7,440 $1,823 24.5%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 13 18 $3,978 $1,428 35.9%
99221 Initial hospital inpatient care per day, typically 30 minutes Facility 2022 12 14 $3,528 $1,225 34.7%
90935 Hemodialysis procedure with physician evaluation Facility 2022 17 17 $3,995 $1,048 26.2%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 198 562 $98,350 $33,559 34.1%
99215 Established patient outpatient visit, total time 40-54 minutes Facility 2021 152 175 $56,000 $21,937 39.2%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 182 241 $53,261 $18,365 34.5%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 67 144 $36,432 $12,735 35.0%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 79 84 $28,224 $9,684 34.3%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 45 49 $24,304 $8,385 34.5%

About Dr. Vasil Peev, M.D

Dr. Vasil Peev, M.D is a Nephrology healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/21/2008. The National Provider Identifier (NPI) number assigned to this provider is 1427229087.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vasil Peev, M.D has received a total of $22,436 in payments from pharmaceutical and medical device companies, with $2,345 received in 2024. These payments were reported across 53 transactions from 13 companies. The most common payment nature is "Honoraria" ($13,610).

As a Medicare-enrolled provider, Peev has provided services to 2,948 Medicare beneficiaries, totaling 5,198 services with total Medicare billing of $438,510. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.

Practice Information

  • Specialty Nephrology
  • Location Chicago, IL
  • Active Since 03/21/2008
  • Last Updated 02/20/2015
  • Taxonomy Code 207RN0300X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1427229087

Products in Payments

  • PROCYSBI (Drug) $8,010
  • KRYSTEXXA (Biological) $6,260
  • ACTHAR (Biological) $4,020
  • TARPEYO (Drug) $2,376
  • SOLIRIS (Drug) $462.04
  • ENTRESTO (Drug) $215.00
  • Envarsus XR (Drug) $140.98
  • PURIFIED CORTROPHIN GEL (Drug) $120.69
  • Rayaldee (Drug) $69.47
  • Envarsus (Drug) $56.00
  • ANDEXXA (Biological) $49.74

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nephrology Doctors in Chicago